Cargando…
Methylome analysis identifies a Wilms tumor epigenetic biomarker detectable in blood
BACKGROUND: Wilms tumor is the most common pediatric renal malignancy and there is a clinical need for a molecular biomarker to assess treatment response and predict relapse. The known mutated genes in this tumor type show low mutation frequencies, whereas aberrant methylation at 11p15 is by far the...
Autores principales: | Charlton, Jocelyn, Williams, Richard D, Weeks, Mark, Sebire, Neil J, Popov, Sergey, Vujanic, Gordan, Mifsud, William, Alcaide-German, Marisa, Butcher, Lee M, Beck, Stephan, Pritchard-Jones, Kathy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310621/ https://www.ncbi.nlm.nih.gov/pubmed/25134821 http://dx.doi.org/10.1186/s13059-014-0434-y |
Ejemplares similares
-
Comparative methylome analysis identifies new tumour subtypes and biomarkers for transformation of nephrogenic rests into Wilms tumour
por: Charlton, Jocelyn, et al.
Publicado: (2015) -
Multiple mechanisms of MYCN dysregulation in Wilms tumour
por: Williams, Richard D., et al.
Publicado: (2015) -
TP53 Mutational Status Is a Potential Marker for Risk Stratification in Wilms Tumour with Diffuse Anaplasia
por: Maschietto, Mariana, et al.
Publicado: (2014) -
miRNA Profiles as a Predictor of Chemoresponsiveness in Wilms’ Tumor Blastema
por: Watson, Jenny A., et al.
Publicado: (2013) -
Stratification of Wilms tumor by genetic and epigenetic analysis
por: Scott, Richard H., et al.
Publicado: (2012)